A Dose-Escalation Study Evaluating the Combination of Trastuzumab Emtansine (T-DM1) With Neratinib in Women With Metastatic HER2-Positive Breast Cancer
Clinical trial NCT02236000 · COMPLETED
Trial details
- NCT number
- NCT02236000
- Sponsor
- NSABP Foundation Inc
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2020-12-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.